
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines






